Real-world evidence (RWE) presented at the 2023 Transplantation and Cellular Therapy Meeting compared and contrasted outcomes for patients receiving inpatient vs. outpatient CAR T-cell therapy for mantle cell lymphoma (MCL) and follicular lymphoma (FL). Patients with FL fared better with outpatient […]
Housing Instability Worsens Health Outcomes
Astronomical rent and home prices are driving the ever-worsening affordable housing crisis. A newly published article in JAMA Network Open explores the link between housing instability and health outcomes, finding that displacement and unsafe living situations related to unaffordable housing are […]
Teppeza Improves Vision for Patients with Thyroid Eye Disease in Real-World Data Study
Results from a real-world data analysis show that Horizon Therapeutics’ Teppeza improves vision for patients with dysthyroid optic neuropathy (DON), a progressive eye disease related to thyroid dysfunction. Blindness is a leading fear of patients with the disease, making the therapy a promising […]
Talking Real-World Evidence and Individualized NSCLC Therapy with Daryl Pritchard
Precision therapy for non-small cell lung cancer (NSCLC) could save patients’ lives, but access to these treatments and the required genomic and biomarker testing are out of reach for many. In a new OncLive interview, Ashling Wahner talks about recently presented research into the impact of targeted […]
Modern Drug Development Depends on RWD
Drug developers and other life sciences organizations now have access to troves of real-world data (RWD) that can accelerate research and market access efforts. RWD and the real-world evidence generated let researchers study the effects of drugs in real-world conditions and make comparisons that may […]
Leveraging Real-World Data in Research and FDA Approval Applications
The US Food and Drug Administration (FDA) has increasingly encouraged drug developers to use real-world data (RWD) and the real-world evidence (RWE) generated from it in applications. As a result, more and more companies are using RWD and RWE in novel clinical trial designs, applications to extend […]
Merck Announces Foundry DevTools Data Library is Now Free on Github
Merck KGaA has announced that its Foundry DevTools library, created with Palantir Technologies, will be freely available to users on Github, an open-source repository of code and software development resources. Merck and other pharma giants have used the platform for drug development and real-world […]
Real-World Data Study Identifies Negative Health Outcomes in Long COVID Patients One Year Out
A newly published study in JAMA Health Outcomes found several adverse health outcomes in people living with long COVID one year after their initial infection. The researchers analyzed data from 13,435 people with long COVID symptoms and nearly 27,000 without it, finding that those with long COVID […]
iCAD to Present Real-World Evidence Supporting Profound AI as Diagnostic Tool for Breast Cancer
The medical technology company iCAD is set to present new real-world evidence (RWE) at the European Congress of Radiology (ECR) 2023 supporting its ProfoundAI software in assisting radiologists with breast cancer detection and assessment. The company will also display its Breast AI platform at its […]
HealthCore Changes Name to Carelon Research
The healthcare data company HealthCore announced today, March 1st, that it has undergone a name change. The company, now dubbed Carelon Research, will continue its dedication to providing its healthcare data and evidence generation services to its clients across industry, academia, and other life […]
